Revenue: As of FY2025 Q3, the actual value is USD 263.6 M, missing the estimate of USD 267.14 M.EPS: As of FY2025 Q3, the actual value is USD 0.22, beating the estimate of USD 0.12.EBIT: As of FY2025 Q3, the actual value is USD 25.1 M.<h3>Segment Revenue</h3><ul><li>Total Net Service Revenue: $263.6 million, a 3.9% increase from $253.6 million in Q3 2024.</li><li>Home Health Net Service Revenue: $200.5 million, a slight decrease of 0.2% from $201.0 million in Q3 2024.</li><li>Hospice Net Service Revenue: $63.1 million, a 20.0% increase from $52.6 million in Q3 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income Attributable to Enhabit, Inc.: $11.1 million, compared to a net loss of - $110.2 million in Q3 2024.</li><li>Gross Margin: 48.5%, up from 48.1% in Q3 2024.</li><li>Adjusted EBITDA: $27.0 million, a 10.2% increase from $24.5 million in Q3 2024.</li><li>Adjusted EBITDA Margin: 10.2%, up from 9.7% in Q3 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $66.3 million for the nine months ended September 30, 2025, compared to $55.3 million for the same period in 2024.</li><li>Adjusted Free Cash Flow: $64.8 million for the nine months ended September 30, 2025, compared to $58.3 million for the same period in 2024.</li><li>Adjusted Free Cash Flow for Q3 2025: $36.9 million, compared to $31.2 million in Q3 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Home Health Admissions: Increased by 3.6% year-over-year, with non-Medicare admissions up by 10.4%.</li><li>Home Health Average Daily Census (ADC): 41,451, an increase of 3.7% from the previous year.</li><li>Hospice Average Daily Census (ADC): 4,077, an increase of 12.6% from the previous year.</li></ul><h3>Outlook / Guidance</h3><ul><li>The company updated its 2025 guidance with net service revenue expected to be between $1,058 million and $1,063 million, adjusted EBITDA between $106 million and $109 million, and adjusted EPS between $0.50 and $0.56.</li></ul>

Enhabit Home Health & Hospice | 8-K: FY2025 Q3 Revenue Misses Estimate at USD 263.6 M